| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $3.69M | $894.30K | $960.69K | $942.87K | $1.16M |
| R&D | $1.21M | $50.00K | – | $54.27K | $158.00K |
| SG&A | $2.49M | $844.30K | $960.69K | $888.60K | $998.10K |
| Operating Income | -$3.69M | -$894.30K | -$960.69K | -$942.87K | -$1.16M |
| Interest Expense | – | – | – | – | $588.27K |
| Tax Expense | – | – | – | – | $0.00 |
| Net Income | -$1.96M | -$1.51M | -$1.58M | -$1.51M | -$1.74M |
| EPS (basic) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | -0.0100 |
| EPS (diluted) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | – |
| Shares (diluted) | $444.86M | $413.13M | $397.74M | $371.60M | – |